Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.
Shinsuke SasadaNorio MasumotoEri SuzukiSatoshi SueokaNoriko GodaKeiko KajitaniAkiko EmiTakayuki KadoyaMorihito OkadaPublished in: European journal of nuclear medicine and molecular imaging (2019)
RI determined using delayed-phase FDG PET/CT is associated with malignant features in breast cancers with significant FDG uptake. Dual-phase imaging was helpful in distinguishing luminal A-like breast cancer from luminal B-like, HER2-positive, and triple-negative breast cancers.